MR编号 | FI/H/1119/001 |
---|
药品名称 | Naloxone Accord 0,4 mg/ml |
---|
活性成分 | - Naloxone hydrochloride dihydrate 0.4 mg/ml
|
---|
剂型 | Solution for injection in pre-filled syringe |
---|
上市许可持有人 | Accord Healthcare B.V.
Winthontlaan 200
3526 KV UTRECHT
Netherlands |
---|
参考成员国 - 产品名称 | Finland (FI) |
---|
互认成员国 - 产品名称 | - Portugal (PT)
- Italy (IT)
- Sweden (SE)
- Norway (NO)
- Germany (DE)
Naloxone Accord 0.4 mg/ml Injektions-/Infusionslösung in einer Fertigspritze - Poland (PL)
Naloxone Accord - Denmark (DK)
- Czechia (CZ)
Naloxone Accord - Belgium (BE)
Naloxone Accord 0,4 mg/ml Solution injectable/pour perfusion en seringue préremplie - Netherlands (NL)
- Ireland (IE)
- Austria (AT)
- France (FR)
- Spain (ES)
|
---|
许可日期 | 2022/12/22 |
---|
最近更新日期 | 2024/11/25 |
---|
药物ATC编码 | |
---|
申请类型 | - TypeLevel1:Abridged
- TypeLevel2:Initial Application
- TypeLevel3:Other Generic application Art 10.3 Dir 2001/83/EC
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|